3rd Annual Lung Health in the District Grand Rounds: Spotlight on Women’s Lung Health: Early Diagnosis, Lifesaving Impact

Wednesday, November 12, 2025, 12:15 PM - 1:15 PM, MWHC True Auditorium/TEAMS, Washington, DC

Lung cancer remains the leading cause of cancer-related death among women in the United States—claiming more lives than breast, ovarian, and cervical cancers combined. Yet, it continues to receive disproportionately low attention in public discourse, research funding, and early detection efforts. To confront this urgent disparity, MedStar Georgetown Cancer Institute at Washington Hospital Center and DC Health proudly present the 3rd Annual Lung Health in the District Webinar: “Spotlight on Women’s Lung Health: Early Diagnosis, Lifesaving Impact.”

This dynamic, multidisciplinary event brings together esteemed experts from the NYU Langone’s Perlmutter Cancer Center,  the University of Maryland and the DC Cancer Registry to explore the complex challenges surrounding early lung cancer detection in women. Through insightful presentations and interactive dialogue, attendees will gain actionable knowledge, access educational resources for patient outreach, and engage directly with faculty during a live Q&A session.

1. Increase Awareness and Education Educate healthcare professionals and the public about the rising incidence of lung cancer in women Promote awareness that lung cancer affects non-smokers, especially women, to reduce stigma and improve early detection.
2. Enhance Early Detection and Diagnosis Develop and disseminate guidelines for recognizing subtle symptoms of lung cancer in women. Train clinicians to avoid gender-based diagnostic bias and consider lung cancer in younger and non-smoking female patients. Ensuring that all genders with a smoking history are appropriately screened for Lung cancer screening eligibility
3. Advance Research and Data Collection Support studies investigating biological, hormonal, and environmental factors contributing to increased lung cancer rates in women. Encourage inclusion of women—especially non-smokers and minorities—in lung cancer clinical trials.
4. Improve Genetic Screening and Personalized Treatment Promote genetic testing for mutations like EGFR in women diagnosed with lung cancer. Expand access to targeted therapies tailored to genetic profiles common in female patients.
5. Combat Medical Stereotypes and Bias Implement training programs to address gender stereotypes in lung cancer diagnosis and treatment. Advocate for equitable healthcare practices that recognize the unique presentation of lung cancer in women.

For Teams Details, please register by Clicking on the Register Tab. 

If you have any questions or need additional information, please email Namita Puran at [email protected]

In support of improving patient care, this activity has been planned and implemented by MedStar Health and DC Health. MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credits for learning and change.

Nurses: This activity is approved for 1.0 ANCC contact hour. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Physicians: MedStar Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Physician Assistants:

MedStar Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Social Workers:  

As a Jointly Accredited Organization, MedStar Health is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. MedStar Health maintains responsibility for this course. Social workers completing this course receive 1.0 clinical continuing education credits. 

AMA PRA Category 1 Credits™ Physician (1.00 hours), ASWB Social Worker: Clinical (1.00 hours), Interprofessional Continuing Education (1.00 hours), Non-Physician Member of the Healthcare Team (1.00 hours), Nurse - ANCC (1.00 hours), Physician Assistant - AAPA (1.00 hours)

Mitigation of Relevant Financial Relationships

No commercial support has been provided for this activity.

The following Planning Committee Members have no relevant financial relationships with ineligible companies to disclose:Ti-Hesia Jackson, MSN; Bleta Hamza, ACNP; Namita Puran, CRNP; Claire Kent, PA; Kate Doran, MPH

The following Planning Committee members have reported all relevant financial relationships with ineligible companies:Jessica Wang Memoli, MD- Membership on Advisory Committees or Review Panels, Board Membership, etc.-Janssen Pharmaceutical Companies of Johnson & Johnson (Relationship has ended)|Consulting Fee-Olympus (Relationship has ended)

All relevant financial relationships have been mitigated.

Wednesday, November 12, 2025